Stocks Health care BBLGW

NASDAQ · Health care

Bone Biologics Corp (BBLGW)

It posted a net loss of $2.9M. At June 30, 2026 it held $4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

What Bone Biologics Corp does

Bone Biologics Corp is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker BBLGW.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Bone Biologics Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 16, 2026
   Stock exchange listing notice 8-K
2. August 28, 2026
   Proxy statement DEF 14A
3. August 18, 2026
   Preliminary proxy statement PRE 14A
4. August 14, 2026
   Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.43 versus -$1.33.
5. July 24, 2026
   Securities offering prospectus 424B3
6. July 23, 2026
   Investor disclosure 8-K
7. July 20, 2026
   Additional proxy material DEFA14A
8. July 17, 2026
   Shelf registration to sell securities S-3
9. July 16, 2026
   Other event 8-K
10. July 9, 2026
    Material agreement 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on January 21, 2026. Insider transactions on SEC

Who owns BBLGW

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BBLGW

What does Bone Biologics Corp do?

Bone Biologics Corp is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker BBLGW.

Is Bone Biologics Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $2.9M.

When did Bone Biologics Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the stock exchange listing notice from September 16, 2026.

Similar companies

Compare BBLGW with

Compare BBLGW with any company

Follow BBLGW

Get an email when Bone Biologics Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow BBLGW: get an email when it files

Where the numbers come from

Financial figures are the values Bone Biologics Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.